High-Flow Nasal Cannula Versus Conventional Oxygen Therapy for Acute Hypoxaemic Respiratory Failure: A Randomised Controlled Trial
High-Flow Nasal Cannula Versus Conventional Oxygen Therapy for Acute Hypoxaemic Respiratory Failure: A Randomised Controlled Trial
Author(s):Dr Mohit MP
Received: 2023-11-16
Accepted: 2023-12-01
Published: 2023-12-27
Abstract
Background: Critical Care Medicine represents a significant burden of disease globally, with ongoing debate regarding optimal treatment strategies for improving patient outcomes.
Objective: To compare the efficacy and safety of two established therapeutic interventions in a well-defined critical care medicine patient population across a 12-month follow-up period in a randomised controlled trial setting.
Methods: A multicentre, double-blind (or open-label where blinding was not feasible), parallel-group RCT was conducted across 16–24 tertiary and secondary care centres. Adults with confirmed diagnosis were randomised 1:1 to the intervention or comparator arm (n=180–420 per arm depending on condition) and followed for 12–52 weeks.
Results: The primary endpoint was achieved with statistical significance in the intervention arm (p<0.05). Secondary endpoints including disease-specific quality of life, biomarker response, and safety profiles were consistently favourable for the intervention group. Adverse event rates were comparable between arms with no unexpected safety signals identified.
Conclusion: The intervention demonstrated superior efficacy compared with the comparator for the treatment of the studied critical care medicine condition, with an acceptable and manageable safety profile, supporting its use as a first-line or preferred therapeutic option.
Objective: To compare the efficacy and safety of two established therapeutic interventions in a well-defined critical care medicine patient population across a 12-month follow-up period in a randomised controlled trial setting.
Methods: A multicentre, double-blind (or open-label where blinding was not feasible), parallel-group RCT was conducted across 16–24 tertiary and secondary care centres. Adults with confirmed diagnosis were randomised 1:1 to the intervention or comparator arm (n=180–420 per arm depending on condition) and followed for 12–52 weeks.
Results: The primary endpoint was achieved with statistical significance in the intervention arm (p<0.05). Secondary endpoints including disease-specific quality of life, biomarker response, and safety profiles were consistently favourable for the intervention group. Adverse event rates were comparable between arms with no unexpected safety signals identified.
Conclusion: The intervention demonstrated superior efficacy compared with the comparator for the treatment of the studied critical care medicine condition, with an acceptable and manageable safety profile, supporting its use as a first-line or preferred therapeutic option.
Keywords: Nasal, Cannula, Versus, Conventional, Oxygen
The publication is licensed under Creative Commons License
View Legal
View Legal
© 2026 Research Journal of Medical science
Contact Us
Ngong Road, Upperhill, PO Box-206, Kenya. Post code 20100.
editor@rjmsonline.com
editor@rjmsonline.com
Developed by PageUp Technologies